Inflammatory bowel disease-specific health-related quality of life instruments: A systematic review of measurement properties

Health and Quality of Life Outcomes

Volumn 15, Issue 1, 2017, Pages

  Chen, Xin Lin ^a   Zhong, Liang huan ^a   Wen, Yi ^a   Liu, Tian Wen ^a   Li, Xiao Ying ^b   Hou, Zheng Kun ^a   Hu, Yue ^a   Mo, Chuan wei ^a   Liu, Feng Bin ^a  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^b Affiliated Jiangmen Traditional Chinese Medicine Hospital of Ji nan University   (China)

Author keywords

Inflammatory bowel disease; Instrument; Measurement properties; Quality of life

Indexed keywords

CLEVELAND GLOBAL QUALITY OF LIFE; CROHN DISEASE; EMOTION; EUROPE; HUMAN; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE 32; INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE 36; INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE 9; NORTH AMERICA; PADOVA INFLAMMATORY BOWEL DISEASE QUALITY OF LIFE; PHYSICAL ACTIVITY; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; QUALITY OF LIFE INDEX FOR PEDIATRIC INFLAMMATORY BOWEL DISEASE; QUALITY OF LIFE INDEX FOR PEDIATRIC INFLAMMATORY BOWEL DISEASE II; QUALITY OF LIFE INDEX FOR PEDIATRIC INFLAMMATORY BOWEL DISEASE III; RATING FORM OF INFLAMMATORY BOWEL DISEASE PATIENT CONCERN; REVIEW; SHORT HEALTH SCALE; SHORT INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE; SOCIAL BEHAVIOR; SYSTEMATIC REVIEW; ULCERATIVE COLITIS; ADULT; FEMALE; MALE; PSYCHOLOGY; QUESTIONNAIRE; REPRODUCIBILITY; STANDARDS; VALIDATION STUDY;

ADULT; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SURVEYS AND QUESTIONNAIRES; VALIDATION STUDIES AS TOPIC;

EID: 85029544596     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/s12955-017-0753-2     Document Type: Review

References (94)

1. Saxena S, Orley J. Quality of life assessment: the World Health Organization perspective. European psychiatry. 1997;12:263s-6s.
2. Power M, Bullinger M, Harper A. The World Health Organization WHOQOL-100: tests of the universality of quality of life in 15 different cultural groups worldwide. Health Psychol. 1999;18:495-505.
3. Munkholm P, Pedersen N. Evaluation of quality of life in inflammatory bowel disease. In: In: Crohn's Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach.
4. Veríssimo R. Health-related quality of life in inflammatory bowel disease. In: In: Inflammatory Bowel Disease - Advances in Pathogenesis and Management.
5. Irvine EJ. Quality of life of patients with ulcerative colitis: past, present, and future. Inflamm Bowel Dis. 2008;14:554-65.
6. Wexner SD, Frattini JC: Quality of life in Crohn's disease. In: Handbook of Disease Burdens and Quality of Life Measures.
7. Pallis AG, Mouzas IA. Instruments for quality of life assessment in patients with inflammatory bowel disease. Dig Liver Dis. 2000;32:682-8.
8. Alrubaiy L, Rikaby I, Dodds P, Hutchings HA, Williams JG. Systematic review of health-related quality of life measures for inflammatory bowel disease. J Crohns Colitis. 2015;9:284-92.
9. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
10. Eypasch E, Williams JI, Wood-Dauphinee S, Ure BM, Schmulling C, Neugebauer E, Troidl H. Gastrointestinal quality of life index: development, validation and application of a new instrument. Br J Surg. 1995;82:216-22.
11. Kotecha D, Ahmed A, Calvert M, Lencioni M, Terwee CB, Lane DA. Patient-reported outcomes for quality of life assessment in atrial fibrillation: a systematic review of measurement properties. PLoS One. 2016;11:e0165790.
12. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, Bouter LM, de Vet HC. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63:737-45.
13. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, Bouter LM, de Vet HCW. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010;19:539-49.
14. Terwee CB, Mokkink LB, Knol DL, Ostelo RW, Bouter LM, de Vet HC. Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Qual Life Res. 2012;21:651-7.
15. Alrubaiy L, Hutchings HA, Williams JG. Protocol for a prospective multicentre cohort study to develop and validate two new outcome measures for patients with inflammatory bowel disease. BMJ Open. 2013;3:e003192.
16. Rauchensteiner S, Miltenburger C, Schaefer M. PGI25 Development and validation of patient reported outcomes measurement scales for Crohn's disease: the inflammatory bowel disease impact and symptom scales (IBDIMSYS). Value Health. 2007;10:A359.
17. Higgins PD, Harding G, Patrick DL, Revicki DA, Globe G, Viswanathan HN, Trease S, Fitzgerald K, Borie DC, Leidy NK. Tu1124 Development of the Crohn's Disease Patient-Reported Outcomes (CD-PRO) Questionnaire. Gastroenterology. 2013;144:S-768. doi: 10.1016/S0016-5085(13)62840-1.
18. Higgins PD, Harding G, Patrick DL, Revicki DA, Globe G, Viswanathan HN, Trease S, Fitzgerald K, Borie DC, Leidy NK. Tu1123 Development of the Ulcerative Colitis Patient-Reported Outcomes (UC-PRO) Questionnaire. Gastroenterology. 2013;144:S-768. doi: 10.1016/S0016-5085(13)62839-5.
19. Griffiths AM, Nicholas D, Smith C, Munk M, Stephens D, Durno C, Sherman PM. Development of a quality-of-life index for pediatric inflammatory bowel disease: dealing with differences related to age and IBD type. J Pediatr Gastroenterol Nutr. 1999;28:S46-52.
20. Loonen HJ, Grootenhuis MA, Last BF, de Haan RJ, Bouquet J, Derkx BHF. Measuring quality of life in children with inflammatory bowel disease: the impact-II (NL). Qual Life Res. 2002;11:47-56.
21. Ogden CA, Abbott J, Aggett P, Derkx BH, Maity S, Thomas AG. Pilot evaluation of an instrument to measure quality of life in British children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2008;46:117-20.
22. Guyatt G, Mitchell A, Irvine E, Singer J, Williams N, Goodacre R, Tompkins C. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989;96:804-10.
23. Irvine EJ, Zhou Q, Thompson AK. The short inflammatory bowel disease questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. Am J Gastroenterol. 1996;91:1571-8.
24. Love JR, Irvine EJ, Fedorak RN. Quality of life in inflammatory bowel disease. J Clin Gastroenterol. 1992;14:15-9.
25. Alcalá MJ, Casellas F, Fontanet G, Prieto L, Malagelada J. Shortened questionnaire on quality of life for inflammatory bowel disease. Inflamm Bowel Dis. 2004;10:383-91.
26. Drossman DA, Leserman J, Li ZM, Mitchell CM, Zagami EA, Patrick DL. The rating form of IBD patient concerns: a new measure of health status. Psychosom Med. 1991;53:701-12.
27. Farmer RG, Easley KA, Farmer JM. Quality of life assessment by patients with inflammatory bowel disease. Cleve Clin J Med. 1992;59:35-42.
28. Martin A, Leone L, Fries W, Naccarato R. Quality of life in inflammatory bowel disease. Ital J Gastroenterol. 1995;27:450-4.
29. Fazio VW, O'riordain MG, Lavery IC, Church JM, Lau P, Strong SA, Hull T. Long-term functional outcome and quality of life after stapled restorative proctocolectomy. Ann Surg. 1999;230:575-84.
30. Hjortswang H, Järnerot G, Curman B, Sandberg-Gertzén H, Tysk C, Blomberg B, Almer S, Ström M. The short health scale: a valid measure of subjective health in ulcerative colitis. Scand J Gastroenterol. 2001;41:1196-203.
31. Smith GD, Watson R, Palmer KR. Inflammatory bowel disease: developing a short disease specific scale to measure health related quality of life. Int J Nurs Stud. 2002;39:583-90.
32. Alrubaiy L, Cheung WY, Dodds P, Hutchings HA, Russell IT, Watkins A, Williams JG. Development of a short questionnaire to assess the quality of life in Crohn's disease and ulcerative colitis. J Crohns Colitis. 2015;9:66-76.
33. Wilburn J, McKenna SP, Twiss J, Kemp K, Campbell S. Assessing quality of life in Crohn's disease: development and validation of the Crohn's life impact questionnaire (CLIQ). Qual Life Res. 2015;24:2279-88.
34. Otley A, Smith C, Nicholas D, Munk M, Avolio J, Sherman PM, Griffiths AM. The IMPACT questionnaire: a valid measure of health-related quality of life in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2002;35:557-63.
35. Loonen HJ, Grootenhuis MA, Last BF, Koopman HM, Derkx HHF. Quality of life in paediatric inflammatory bowel disease measured by a generic and a disease-specific questionnaire. Acta Paediatr. 2002;91:348-54.
36. Ogden CA, Akobeng AK, Abbott J, Aggett P, Sood MR, Thomas AG. Validation of an instrument to measure quality of life in British children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2011;53:280-6.
37. Irvine EJ. Quality of life-measurement in inflammatory bowel disease. Scand J Gastroenterol. 1993;28:36-9.
38. Irvine EJ, Feagan BG, Wong CJ. Does self-administration of a quality of life index for inflammatory bowel disease change the results? J Clin Epidemiol. 1996;49:1177-85.
39. Jelsness-Jørgensen LP, Moum B, Bernklev T. Worries and concerns among inflammatory bowel disease patients followed prospectively over one year. Gastroenterol Res Pract. 2011;2011:492034.
40. Jowett SL, Seal CJ, Barton JR, Welfare MR. The short inflammatory bowel disease questionnaire is reliable and responsive to clinically important change in ulcerative colitis. Am J Gastroenterol. 2001;96:2921-8.
41. Rose M, Fliege H, Hildebrandt M, Körber J, Arck P, Dignass A, Klapp B. Validation of the new German translation version of the "short inflammatory bowel disease questionnaire" (SIBDQ). Z Gastroenterol. 2000;38:277-86.
42. Lam MY, Lee H, Bright R, Korzenik JR, Sands BE. Validation of interactive voice response system administration of the short inflammatory bowel disease questionnaire. Inflamm Bowel Dis. 2009;15:599-607.
43. López-Vivancos J, Casellas F, Badia X, Vilaseca J, Malagelada JR. Validation of the Spanish version of the inflammatory bowel disease questionnaire on ulcerative colitis and Crohn's disease. Digestion. 1999;60:274-80.
44. Samsamikor M, Daryani NE, Asl PR, Hekmatdoost A. Anti-inflammatory effects of resveratrol in patients with ulcerative colitis: a randomized, double-blind. Placebo-controlled Pilot Study Arch Med Res. 2015;46:280-5.
45. Jelsness-Jørgensen L-P, Bernklev T, Moum B. Quality of life in patients with inflammatory bowel disease: translation, validity, reliability and sensitivity to change of the Norwegian version of the short health scale (SHS). Qual Life Res. 2012;21:1671-6.
46. McDermott E, Keegan D, Byrne K, Doherty GA, Mulcahy HE. The short health scale: a valid and reliable measure of health related quality of life in English speaking inflammatory bowel disease patients. J Crohn's Colitis. 2013;7:616-21.
47. Stjernman H, Grännö C, Järnerot G, Ockander L, Tysk C, Blomberg B, Ström M, Hjortswang H. Short health scale: a valid, reliable, and responsive instrument for subjective health assessment in Crohn's disease. Inflamm Bowel Dis. 2008;14:47-52.
48. Otley AR, Griffiths AM, Hale S, Kugathasan S, Pfefferkorn M, Mezoff A, Rosh J, Tolia V, Markowitz J, Mack D. Health-related quality of life in the first year after a diagnosis of pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:684-91.
49. Perrin JM, Kuhlthau K, Chughtai A, Romm D, Kirschner BS, Ferry GD, Cohen SA, Gold BD, Heyman MB, Baldassano RN. Measuring quality of life in pediatric patients with inflammatory bowel disease: psychometric and clinical characteristics. J Pediatr Gastroenterol Nutr. 2008;46:164-71.
50. Haapamäki J, Roine RP, Sintonen H, Kolho KL. Health-related quality of life in paediatric patients with inflammatory bowel disease related to disease activity. J Paediatr Child Health. 2011;47:832-7.
51. Otley AR, Xu S, Yan S, Olson A, Liu G, Griffiths AM. IMPACT-III is a valid, reliable and responsive measure of health-related quality of life in pediatric Crohn's disease. J Pediatr Gastroenterol Nutr. 2006;43:S49.
52. Gray WN, Denson LA, Baldassano RN, Hommel KA. Disease activity, behavioral dysfunction, and health-related quality of life in adolescents with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:1581-6.
53. Abdovic S, Mocic Pavic A, Milosevic M, Persic M, Senecic-Cala I, Kolacek S. The IMPACT-III (HR) questionnaire: a valid measure of health-related quality of life in Croatian children with inflammatory bowel disease. J Crohn's Colitis. 2013;7:908-15.
54. Werner H, Landolt MA, Buehr P, Koller R, Nydegger A, Spalinger J, Heyland K, Schibli S, Braegger CP. Validation of the IMPACT-III quality of life questionnaire in Swiss children with inflammatory bowel disease. J Crohns Colitis. 2014;8:641-8.
55. W-y C, Garratt AM, Russell IT, Williams JG. The UK IBDQ- a British version of the inflammatory bowel disease questionnaire: development and validation. J Clin Epidemiol. 2000;53:297-306.
56. Han SW, McColl E, Steen N, Barton JR, Welfare MR. The inflammatory bowel disease questionnaire: a valid and reliable measure in ulcerative colitis patients in the north east of England. Scand J Gastroenterol. 1998;33:961-6.
57. Russel MG, Pastoor CJ, Brandon S, Rijken J, Engels L, Van der Heijde D, Stockbrügger RW. Validation of the Dutch translation of the inflammatory bowel disease questionnaire (IBDQ): a health-related quality of life questionnaire in inflammatory bowel disease. Digestion. 1997;58:282-8.
58. Pontes RMA, Miszputen SJ, Ferreira-Filho OF, Miranda C, Ferraz MB. Quality of life in patients with inflammatory bowel diseases: translation to Portuguese language and validation of the "inflammatory bowel disease questionnaire"(IBDQ). Arq Gastroenterol. 2004;41:137-43.
59. Vlachonikolis IG, Pallis AG, Mouzas IA. Improved validation of the inflammatory bowel disease questionnaire and development of a short form in Greek patients. Am J Gastroenterol. 2003;98:1802-12.
60. Hjortswang H, Järnerot G, Curman B, Sandberg-Gertzén H, Tysk C, Blomberg B, Almer S, Ström M. Validation of the inflammatory bowel disease questionnaire in Swedish patients with ulcerative colitis. Scand J Gastroenterol. 2001;36:77-85.
61. Bernklev T, Moum B, Moum T. Inflammatory bowel south-eastern Norway Group of G. Quality of life in patients with inflammatory bowel disease: translation, data quality, scaling assumptions, validity, reliability and sensitivity to change of the Norwegian version of IBDQ. Scand J Gastroenterol. 2002;37:1164.
62. Hashimoto H, Green J, Iwao Y, Sakurai T, Hibi T, Fukuhara S. Reliability, validity, and responsiveness of the Japanese version of the inflammatory bowel disease questionnaire. J Gastroenterol. 2003;38:1138-43.
63. Hauser W, Dietz N, Grandt D, Steder-Neukamm U, Janke KH, Stein U, Stallmach A. Validation of the inflammatory bowel disease questionnaire IBDQ-D, German version, for patients with ileal pouch anal anastomosis for ulcerative colitis. Zeitschrift fur Gastroenterologie. 2004;42:131-40.
64. Ren WH, Lai M, Chen Y, Irvine EJ, Zhou YX. Validation of the mainland Chinese version of the inflammatory bowel disease questionnaire (IBDQ) for ulcerative colitis and Crohn's disease. Inflamm Bowel Dis. 2007;13:903-10.
65. Leong RWL, Lee YT, Ching JYL, Sung JJY. Quality of life in Chinese patients with inflammatory bowel disease: validation of the Chinese translation of the inflammatory bowel disease questionnaire. Aliment Pharmacol Ther. 2003;17:711-8.
66. Kim WH, Cho YS, Yoo HM, Park IS, Park EC, Lim JG. Quality of life in Korean patients with inflammatory bowel diseases: ulcerative colitis, Crohn's disease and intestinal Behcet's disease. Int J Color Dis. 1999;14:52-7.
67. Abdul-Baki H, ElHajj I, El-Zahabi L, Azar C, Aoun E, Zantout H, Nasreddine W, Ayyach B, Mourad FH, Soweid A. Clinical epidemiology of inflammatory bowel disease in Lebanon. Inflamm Bowel Dis. 2006;13:475-80.
68. Oliveira S, Zaltman C, Elia C, Vargens R, Leal A, Barros R, Fogaça H. Quality-of-life measurement in patients with inflammatory bowel disease receiving social support. Inflamm Bowel Dis. 2007;13:470-4.
69. Ciccocioppo R, Klersy C, Russo ML, Valli M, Boccaccio V, Imbesi V, Ardizzone S, Porro GB, Corazza GR. Validation of the Italian translation of the inflammatory bowel disease questionnaire. Dig Liver Dis. 2011;43:535-41.
70. Maleki I, Taghvaei T, Barzin M, Amin K, Khalilian A. Validation of the Persian version of the inflammatory bowel disease questionnaire (IBDQ) in ulcerative colitis patients. Caspian J Intern Med. 2015;6:20-4.
71. Kennedy AP, Nelson E, Reeves D, Richardson G, Roberts C, Robinson A, Rogers AE, Sculpher M, Thompson DG. A randomised controlled trial to assess the effectiveness and cost of a patient orientated self management approach to chronic inflammatory bowel disease. Gut. 2004;53:1639-45.
72. Schreiber S, Rutgeerts P, Fedorak RN, Khaliq-Kareemi M, Kamm MA, Boivin M, Bernstein CN, Staun M, Thomsen OØ, Innes A. A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease. Gastroenterology. 2005;129:807-18.
73. Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet. 2002;359:1541-9.
74. Greenberg GR, Feagan BG, Martin F, Sutherland LR, Thomson AB, Williams CN, Nilsson L, Persson T. Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian inflammatory bowel disease study group. Gastroenterology. 1996;110:45-51.
75. Van Assche G, Magdelaine-Beuzelin C, D'Haens G, Baert F, Noman M, Vermeire S, Ternant D, Watier H, Paintaud G, Rutgeerts P. Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial. Gastroenterology. 2008;134:1861-8.
76. Hjortswang H, Strom M, Almeida RT, Almer S. Evaluation of the RFIPC, a disease-specific health-related quality of life questionnaire, in Swedish patients with ulcerative colitis. Scand J Gastroenterol. 1997;32:1235-40.
77. Jaghult S, Saboonchi F, Johansson U-B, Wredling R, Kapraali M. Factor structures of the Swedish version of the RFIPC: investigating the validity of measurements of IBD Patients' worries and concerns. Gastroenterology Research. 2010;3:191-200.
78. Jelsness-Jørgensen LP, Bernklev T, Henriksen M, Torp R, Moum BA. Chronic fatigue is associated with impaired health-related quality of life in inflammatory bowel disease. Aliment Pharmacol Ther. 2011;33:106-14.
79. Torres EA, Pérez C, Chinea B, Arroyo J, Aponte N, Guzmán A, Magno P, Provenzale D. Evaluation of the rating form for inflammatory bowel diseases patients concerns (RFIPC) spanish translation in Puerto Ricans with IBD. Am J Gastroenterol. 2000;118:2643.
80. Blondel-Kucharski F, Chircop C, Marquis P, Cortot A, Baron F, Gendre J-P, Colombel F. Health-related quality of life in Crohn's disease: a prospective longitudinal study in 231 patients. Am J Gastroenterol. 2001;96:2915-20.
81. Levenstein S, Li Z, Almer S, Barbosa A, Marquis P, Moser G, Sperber A, Toner B, Drossman DA. Cross-cultural variation in disease-related concerns among patients with inflammatory bowel disease. Am J Gastroenterol. 2001;96:1822-30.
82. Argyriou K, Roma E, Kapsoritakis A, Tsakiridou E, Oikonomou K, Manolakis A, Potamianos S. The rating form of IBD patient concerns: translation, validation, and first implementation of the Greek version. Gastroenterol Res Pract. 2017;2017:6267175.
83. Casellas F, Alcalá MJ, Prieto L, Miró JR, Malagelada JR. Assessment of the influence of disease activity on the quality of life of patients with inflammatory bowel disease using a short questionnaire. Am J Gastroenterol. 2004;99:457-61.
84. Casellas F, Arenas JI, Baudet JS, Fabregas S, Garcia N, Gelabert J, Medina C, Ochotorena I, Papo M, Rodrigo L. Impairment of health-related quality of life in patients with inflammatory bowel disease: a Spanish multicenter study. Inflamm Bowel Dis. 2005;11:488-96.
85. Scarpa M, Victor CJ, O'Connor BI, Cohen Z, McLeod RS. Validation of an English version of the Padova quality of life instrument to assess quality of life following ileal pouch anal anastomosis. J Gastrointest Surg. 2009;13:416-22.
86. Somashekar U, Gupta S, Soin A, Nundy S. Functional outcome and quality of life following restorative proctocolectomy for ulcerative colitis in Indians. Int J Color Dis. 2010;25:967-73.
87. Lee J, Lee EH, Moon SH. A systematic review of measurement properties of the instruments measuring health-related quality of life in patients with irritable bowel syndrome. Qual Life Res. 2016;25:2985-95.
88. Lee J, Kim SH, Moon SH, Lee EH. Measurement properties of rheumatoid arthritis-specific quality-of-life questionnaires: systematic review of the literature. Qual Life Res. 2014;23:2779-91.
89. Heinl D, Prinsen CAC, Sach T, Drucker AM, Ofenloch R, Flohr C, Apfelbacher C. Measurement properties of quality-of-life measurement instruments for infants, children and adolescents with eczema: a systematic review. Br J Dermatol. 2017;176:878-89.
90. Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis. 2006;12:S3-9.
91. Patrick DL, Burke LB, Powers JH, Scott JA, Rock EP, Dawisha S, O'Neill R, Kennedy DL. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health. 2007;10:S125-37.
92. The WHOQOL Group. The World Health Organization quality of life assessment (WHOQOL): development and general psychometric properties. Soc Sci Med. 1998;46:1569-85.
93. WHOQoL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28:551-8.
94. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11:570-9.